SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001477932-18-004763
Filing Date
2018-10-09
Accepted
2018-10-09 06:52:28
Documents
8
Period of Report
2018-10-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ipix_8k.htm 8-K 26667
2 CERTIFICATE OF DESIGNATION ipix_ex31.htm EX-3.1 134157
3 FORM OF WARRANT ipix_ex41.htm EX-4.1 69959
4 OPINION ipix_ex51.htm EX-5.1 11792
5 OPINION ipix_ex52.htm EX-5.2 7169
6 SECURITIES PURCHASE AGREEMENT ipix_ex101.htm EX-10.1 430926
7 PRESS RELEASE ipix_ex991.htm EX-99.1 8646
8 ipix_ex52img1.jpg GRAPHIC 6772
  Complete submission text file 0001477932-18-004763.txt   700236
Mailing Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915
Business Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915 978-921-4125
Innovation Pharmaceuticals Inc. (Filer) CIK: 0001355250 (see all company filings)

IRS No.: 134303398 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-37357 | Film No.: 181112138
SIC: 2834 Pharmaceutical Preparations